Post-COVID Syndrome in Children: One-Time Survey Study of Parents’ Opinion

Background. COVID-19 symptoms often persist for a long time, it indicates the post-COVID syndrome development. Its frequency in children population is generally studied by interviewing the children themselves. This approach limits the risk evaluation of post-COVID syndrome development in young children who are unable to describe the persistent symptoms due to their age.

Objective. The aim of the study is to evaluate the prevalence of post-COVID syndrome in children and its effect on their daily activities by interviewing parents.

Methods. The survey covered parents of children (aged from 3 months to 18 years) who suffered laboratory-confirmed COVID-19 in 2021–2022 but not earlier than 12 weeks before study initiation. The survey was conducted on-line. The presence of the symptoms (persisted or occurred 12 weeks after COVID-19), its impact on children’s daily life, the need for medical treatment or doctor's advice (due to these post-covid symptoms) and vaccination against novel coronavirus infection were evaluated. Incidence of post-COVID syndrome was analyzed in subgroups based on sex, age (< 3 years, 3–6 and 7–17 years), and disease severity.

Results. Invitations to participate in the study were sent to 2292 parents of all children registered at the clinic and suffered from COVID-19 via WhatsApp and Telegram messengers. 1533 (66.9%) of them agreed to take part in the survey, and 1258 (54.8%) filled out the questionnaire in full. The survey has revealed that at least one symptom that persisted or occurred 12 weeks after COVID-19 was noted by parents in 764 out of 1258 (60.6%) children (more often in the older age group and in severe cases). Significant negative impact of symptoms on children’s daily life was noted by 251 out of 764 (32.9%) respondents. Parents of 734 out of 764 (96.1%) children have visited a doctor due to post-COVID syndrome symptoms.

Conclusion. Post-COVID syndrome develops in more than 60% of children after laboratory-confirmed COVID-19, according to parents. However, we have reasons to believe that parental estimations could overestimate the prevalence of post-COVID syndrome.

1. Baimukhambetova DV, Gorina AO, Rumyantsev MA, et al. PostCOVID condition in adults and children. Pul’monologiya. 2021;31(5): 562–570. (In Russ). doi: https://doi.org/10.18093/0869-01892021-31-5-562-570]

2. Stephenson T, Allin B, Nugawela MD, et al. Long COVID (postCOVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022;107(7):674–680. doi: https://doi.org/10.1136/archdischild-2021-323624

3. O’Mahoney LL, Routen A, Gillies C, et al. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2022;55:101762. doi: https://doi.org/10.1016/j.eclinm.2022.101762

4. Pazukhina E, Andreeva M, Spiridonova E, et al. Prevalence and risk factors of post-COVID-19 condition in adults and children at 6 and 12 months after hospital discharge: a prospective, cohort study in Moscow (StopCOVID). BMC Med. 2022;20(1):244. doi: https://doi.org/10.1186/s12916-022-02448-4

5. Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12(1):9950. doi: https://doi.org/10.1038/s41598-022-13495-5

6. Osmanov IM, Spiridonova E, Bobkova P, et al. Risk factors for post-COVID-19 condition in previously hospitalised children using the ISARIC Global follow-up protocol: a prospective cohort study. Eur Respir J. 2022;59(2):2101341. doi: https://doi.org/10.1183/13993003.01341-2021

7. Garazzino S, Denina M, Pruccoli G, et al. Long COVID-19/postCOVID condition in children: do we all speak the same language? Ital J Pediatr. 2023;49(1):12. doi: https://doi.org/10.1186/s13052-023-01417-8

8. Namazova-Baranova L, Karkashadze G, Zelenkova I, et al. A non-randomized comparative study of olfactory and gustatory functions in children who recovered from COVID-19 (1-year followup). Front Pediatr. 2022;10:919061. doi: https://doi.org/10.3389/fped.2022.919061

9. Ivanova ON. Post-COVID syndrome in children. International Research Journal. 2021;(9):35–39. (In Russ). doi: https://doi.org/10.23670/IRJ.2021.9.111.040

10. Chernova TM, Timchenko VN, Barakina EV, et al. Outcome of COVID-19 in children: results of a 12-month follow-up. Jurnal infektologii = Journal Infectology. 2022;14(2):96–106. (In Russ). doi: https://doi.org/10.22625/2072-6732-2022-14-2-96-106

11. Temmoeva LA, Alieva ZM, Kambachokova ZA, et al. Post-COVID Syndrome in Children Residing in the Kabardino-Balkarian Republic. Antibiotics and Chemotherapy. 2022;67(3-4):42–45. (In Russ). doi: https://doi.org/10.37489/0235-2990-2022-67-3-4-42-45

12. Troitskaya LA, Plotnikova IA, Avakyan GG, et al. Neuropsychological evaluation of cognitive disorders in children after COVID-19. Eur J Transl Myol. 2022;32(3):10685. doi: https://doi.org/10.4081/ejtm.2022.10685

13. Eiser C, Varni JW. Health-related quality of life and symptom reporting: similarities and differences between children and their parents. Eur J Pediatr. 2013;172(10):1299–1304. doi: https://doi.org/10.1007/s00431-013-2049-9

14. Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children’s health-related quality of life: an analysis of 13,878 parents’ reliability and validity across age subgroups using the PedsQL 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5:2. doi: https://doi.org/10.1186/1477-7525-5-2

15. Conijn JM, Smits N, Hartman EE. Determining at What Age Children Provide Sound Self-Reports: An Illustration of the ValidityIndex Approach. Assessment. 2020;27(7):1604–1618. doi: https://doi.org/10.1177/1073191119832655

16. Namazova-Baranova Leyla S, Karkashadze Georgiy A, Zelenkova Irina V, et al. Non-Randomized Comparative Study of Olfaction in post-COVID-19 Children. Intermediary Results. Pediatricheskaya farmakologiya — Pediatric pharmacology. 2020;17(6):502–507. (In Russ). doi: https://doi.org/10.15690/pf.v17i6.2201

17. Borch L, Holm M, Knudsen M, et al. Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597–1607. doi: https://doi.org/10.1007/s00431-021-04345-z

18. Rowe ML, Weisleder A. Language Development in Context. Annual Review of Developmental Psychology. 2020;2:201–223.

19. Osobennosti klinicheskikh proyavlenii i lecheniya zabolevaniya, vyzvannogo novoi koronavirusnoi infektsiei (COVID-19) u detei: Methodical Recommendations. Version 2. Ministry of Health of Russia; 2020. 73 p. (In Russ).] Доступно по: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/050/914/original/03062020_дети_COVID-19_v2.pdf. Ссылка активна на 17.05.2023.

20. Propedevtika vnutrennikh boleznei: uchebnoe posobie dlya studentov meditsinskikh vuzov. Ivashkin VM, Sheptulina AA, eds. Moscow: MEDpress-inform; 2003. 240 p. (In Russ).

21. Ked AP, Agaeva PM. Internet-opros kak metod sotsiologicheskogo issledovaniya. Problemy sovremennoi ekonomiki (Novosibirsk). 2015;(27):112–116. (In Russ).

22. Khan AS, Rahman A, Qazi LT. The Relationship Between Internet Usage, Socioeconomic Status, Subjective Health and Social Status. Business & Economic Review. 2016;8:67–82. doi: https://doi.org/dx.doi.org/10.22547/BER/8.SE.5

23. Bosworth ML, Shenhuy B, Walker AS, et al. Risk of new-onset Long Covid following reinfection with SARS-CoV-2: community-based cohort study. medRxiv 2023.04.13.23288522. doi: https://doi.org/10.1101/2023.04.13.23288522

24. Adler L, Israel M, Yehoshua I, et al. Long COVID symptoms in Israeli children with and without a history of SARS-CoV-2 infection: a cross-sectional study. BMJ Open. 2023;13(2):e064155. doi: https://doi.org/10.1136/bmjopen-2022-064155

25. Cortés-Sarabia K, Guzman-Silva V, Martinez-Pacheco KM, et al. Detection of IgA and IgG Antibodies against the Structural Proteins of SARS-CoV-2 in Breast Milk and Serum Samples Derived from Breastfeeding Mothers. Viruses. 2023;15(4):966. doi: https://doi.org/10.3390/v15040966

26. Jammoul M, Naddour J, Madi A, et al. Investigating the possible mechanisms of autonomic dysfunction post-COVID-19. Auton Neurosci. 2023;245:103071. doi: https://doi.org/10.1016/j.autneu.2022.103071

27. Pires BG, Calado RT. Hyper-inflammation and complement in COVID-19. Am J Hematol. 2023;98 Suppl 4:S74–S81. doi: https://doi.org/10.1002/ajh.26746

28. Cárdenas G, Fragoso G, Sciutto E. Neuroinflammation in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) infection: Pathogenesis and clinical manifestations. Curr Opin Pharmacol. 2022;63:102181. doi: https://doi.org/10.1016/j.coph.2021.12.008

29. Konsman JP, Luheshi GN, Bluthé RM, Dantzer R. The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci. 2000;12(12):4434–4446. doi: https://doi.org/10.1046/j.0953-816x.2000.01319.x

30. Kucukkarapinar M, Yay-Pence A, Yildiz Y, et al. Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress. J Neural Transm (Vienna). 2022;129(8):1077–1089. doi: https://doi.org/10.1007/s00702-022-02525-1

31. Kelley KW, Bluthé RM, Dantzer R, et al. Cytokine-induced sickness behavior. Brain Behav Immun. 2003;17 Suppl 1:S112–S118. doi: https://doi.org/10.1016/s0889-1591(02)00077-6